202 related articles for article (PubMed ID: 10618567)
1. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group.
Gambassi G; Forman DE; Lapane KL; Mor V; Sgadari A; Lipsitz LA; Bernabei R
Am Heart J; 2000 Jan; 139(1 Pt 1):85-93. PubMed ID: 10618567
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
[TBL] [Abstract][Full Text] [Related]
3. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
5. A review of the management of heart failure in long-term care residents.
Mann JL; Evans TS
Consult Pharm; 2006 Mar; 21(3):222-8. PubMed ID: 16573369
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
Levy E; Levy P
Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
8. Prescribing and emergency admissions for heart failure in greater Glasgow.
Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
Valdemarsson S; Edvinsson L; Ekman R; Hedner P; Sjöholm A
J Intern Med; 1991 Oct; 230(4):325-31. PubMed ID: 1717629
[TBL] [Abstract][Full Text] [Related]
10. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic treatment of chronic congestive heart failure].
Halawa B
Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
[TBL] [Abstract][Full Text] [Related]
12. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
[TBL] [Abstract][Full Text] [Related]
13. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
[TBL] [Abstract][Full Text] [Related]
14. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
[TBL] [Abstract][Full Text] [Related]
15. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
Stafford RS; Saglam D; Blumenthal D
Arch Intern Med; 1997 Nov; 157(21):2460-4. PubMed ID: 9385297
[TBL] [Abstract][Full Text] [Related]
16. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
Gheorghiade M; Zarowitz BJ
Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
[TBL] [Abstract][Full Text] [Related]
17. Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study.
Maison P; Cunin P; Hemery F; Fric F; Elie N; Del'volgo A; Dubois-Randé JL; Hittinger L; Macquin-Mavier I
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):445-51. PubMed ID: 15940531
[TBL] [Abstract][Full Text] [Related]
18. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
Hackenbruck HA
Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
[TBL] [Abstract][Full Text] [Related]
19. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
20. Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
Hagemeijer F
Am Heart J; 1991 Aug; 122(2):517-22. PubMed ID: 1858635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
